AORT.NYSEArtivion, INC

Form 4: Artivion SVP Sells $331K in Stock Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Artivion's SVP, General Counsel, Jean F. Holloway, sold 7,315 shares of common stock for approximately $331,489.50 on December 3, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • Jean F. Holloway, Senior Vice President and General Counsel of Artivion, Inc. (AORT), reported the sale of common stock.
  • The transactions occurred on December 3, 2025.
  • A total of 7,315 shares of common stock were sold in two separate transactions.
  • The shares were sold at a price of $45.3 per share.
  • The total value of the shares sold amounts to approximately $331,489.50.
  • The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
  • Following these transactions, Jean F. Holloway beneficially owns 156,093 shares of Artivion common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the explicit mention of a Rule 10b5-1 plan indicates a pre-scheduled transaction for personal financial planning, mitigating concerns about opportunistic selling based on non-public information. The amount sold is not exceptionally large relative to the total holdings.

Positives

  • The sale was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction for personal financial planning rather than opportunistic selling based on new, non-public information.

Negatives

  • Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, although this is mitigated by the pre-planned nature.

Future Outlook

No forward-looking statements or guidance were provided in this filing, as it is a report of past insider transactions.

Industry Context

This filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: The sale by a senior executive could be interpreted in various ways, but the 10b5-1 plan suggests it's for personal financial management rather than a signal about company performance. The impact is likely minimal given the routine nature and size of the transaction.

Key Dates

DateDescription
12/03/2025Date of earliest transaction (sale of common stock)
12/04/2025Date the Form 4 was signed and filed

Recommendation

hold

The filing details a routine insider stock sale by a senior executive under a pre-arranged 10b5-1 plan. Such transactions are typically for personal financial planning and do not usually signal a significant change in the company's fundamental outlook or warrant a strong buy or sell recommendation based solely on this information. Investors should consider broader company performance and market conditions.

Keywords

ARTIVION, AORT, insider trading, stock sale, Form 4, executive compensation, 10b5-1 plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.